Sources | Names Used |
---|---|
CTRPv2 | JQ-1:navitoclax (2:1 mol/mol) |
PharmacoGx | JQ-1:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ABCC8 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
mRNA | MAGED4B | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
mRNA | ZNF189 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
mRNA | AC092835.2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
mRNA | GHRH | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0005 |
mRNA | PCDHA10 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
mRNA | MAOB | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
mRNA | SATB1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
mRNA | ASXL3 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
mRNA | ZNF646 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |